Prosecution Insights
Last updated: May 29, 2026

Neonc Technologies Inc.

4 pending office actions • 4 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days

Portfolio Summary

4
Total Pending OAs
4
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

3
Overdue
0
Due this week
0
Due this month
1
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (3)Due ≤ 60 days (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
2
Medium (50%)
0
Easy (0%)
2
Unknown (50%)

Rejection Statute Mix

BucketCases
§103 only2 (50%)
No statute on record2 (50%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

4
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

40 h
Manual time on pending OAs
8 h
Time saved (low, 20%)
14 h
Time saved (mid, 35%)
0.3 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
BROWE, DAVID 1 25.8% +28.7%
LEE, HOI YAN NMN 1 43.1% +77.9%
ZARA, JANE J 1 70.8% +15.9%
RODRIGUEZ, RAYNA B 1 32.4% +21.6%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18251839 TREATMENT OF RECURRENT GIOBLASTOMA WITH PERILLYL ALCOHOL BROWE, DAVID 17d overdue

Interview Candidates (4)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.

App #TitleExaminerDue in
18248733 COMBINATION OF POH AND REMDESIVIR FOR TREATMENT OF CNS INFECTIONS LEE, HOI YAN NMN 134d overdue
18001082 COMPOSITIONS AND METHODS FOR DELIVERING POLYNUCLEOTIDES ZARA, JANE J 118d overdue
18251839 TREATMENT OF RECURRENT GIOBLASTOMA WITH PERILLYL ALCOHOL BROWE, DAVID 17d overdue
17251452 PHARMACEUTICAL COMPOSITIONS COMPRISING POH DERIVATIVES RODRIGUEZ, RAYNA B 55d

Top Art Units

Art UnitApps
1617 1
1693 1
1637 1
1628 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18251839 TREATMENT OF RECURRENT GIOBLASTOMA WITH PERILLYL ALCOHOL BROWE, DAVID 1617 §103 Non-Final OA 17d overdue Pending May 04, 2023
18248733 COMBINATION OF POH AND REMDESIVIR FOR TREATMENT OF CNS INFECTIONS LEE, HOI YAN NMN 1693 Other Non-Final OA 134d overdue Pending Apr 12, 2023
18001082 COMPOSITIONS AND METHODS FOR DELIVERING POLYNUCLEOTIDES ZARA, JANE J 1637 §103 Non-Final OA 118d overdue Pending Dec 08, 2022
17251452 PHARMACEUTICAL COMPOSITIONS COMPRISING POH DERIVATIVES RODRIGUEZ, RAYNA B 1628 Other Non-Final OA 55d Pending Dec 11, 2020

Managing Neonc Technologies Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month